Article Text

other Versions

PDF
Olfactory testing combined with dopamine transporter imaging as a method to detect prodromal Parkinson's disease
  1. Mirthe M Ponsen1,
  2. Diederick Stoffers1,
  3. Erik Ch Wolters1,
  4. Jan Booij2,
  5. Henk W Berendse1
  1. 1Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands
  2. 2Department of Nuclear Medicine, Academic Medical Center, Amsterdam, The Netherlands
  1. Correspondence to Dr M M Ponsen, Department of Neurology, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands; mm.ponsen{at}vumc.nl

Abstract

Objective Olfactory dysfunction is an early and common symptom in Parkinson disease (PD). Previously, the authors demonstrated that idiopathic olfactory dysfunction in first-degree relatives of PD patients is associated with an increased risk of developing PD within 2 years. The aim of the present study was to determine the value of combined olfactory testing and SPECT scanning in predicting future PD in the same population of relatives over a 5-year period.

Methods In a cohort of 361 non-parkinsonian, non-demented first-degree relatives of PD patients, a combination of olfactory processing tasks was used to select groups of hyposmic (n=40) and normosmic (n=38) individuals for a 5-year clinical follow-up evaluation and sequential SPECT scanning, using a dopamine transporter ligand to assess nigrostriatal dopaminergic function at baseline and 5 years from baseline. A validated questionnaire, sensitive to the presence of parkinsonism, was used in the follow-up of the remaining 283 relatives.

Results Five years from baseline, five out of the 40 hyposmic relatives fulfilled clinical diagnostic criteria for PD. None of the other 349 relatives available for follow-up developed PD. All hyposmic individuals developing PD had an abnormal baseline SPECT scan.

Discussion In conclusion, idiopathic hyposmia in first-degree relatives of PD patients is associated with an increased risk of developing clinical PD of 12.5% over a 5-year period. The present data suggest that a two-step approach using olfactory testing followed by SPECT scanning in hyposmic individuals has a very high sensitivity and specificity in detecting PD. The usefulness of this two-step approach needs to be confirmed in larger populations.

  • Parkinson's disease
  • early diagnosis
  • olfaction
  • prodromal period
  • SPECT

Statistics from Altmetric.com

Footnotes

  • Funding Zorgonderzoek Nederland.

  • Competing interests None.

  • Ethics approval Ethics approval was provided by the Health Council of The Netherlands and local medical ethical committees of the VU University Medical Center and the Academic Medical Center.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.